Drug Shortage Report for HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION

Last updated on 2017-10-05 History
Report ID 1700
Drug Identification Number 00872520
Brand name HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION
Common or Proper name HYDROCORTISONE SODIUM SUCCINATE
Company Name TEVA CANADA LIMITED
Market Status CANCELLED POST MARKET
Active Ingredient(s) HYDROCORTISONE
Strength(s) 100MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 10
ATC code H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2016-02-29
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2017-10-05
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2017-03-13 French Compare
v1 2017-03-13 English Compare